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Abstract
Background: Attrition occurs when a participant fails to respond to one or more study waves. The accumulation of
attrition over several waves can lower the sample size and power and create a final sample that could differ in
characteristics than those who drop out. The main reason to conduct a longitudinal study is to analyze repeated
measures; research subjects who drop out cannot be replaced easily. Our group recently investigated factors
affecting nonparticipation (refusal) in the first wave of a population-based study of prostate cancer. In this study we
assess factors affecting attrition in the second wave of the same study. We compare factors affecting
nonparticipation in the second wave to the ones affecting nonparticipation in the first wave.
Methods: Information available on participants in the first wave was used to model attrition. Different sources of
attrition were investigated separately. The overall and race-stratified factors affecting attrition were assessed. Kaplan-
Meier survival curve estimates were calculated to assess the impact of follow-up time on participation.
Results: High cancer aggressiveness was the main predictor of attrition due to death or frailty. Higher Charlson
Comorbidity Index increased the odds of attrition due to death or frailty only in African Americans (AAs). Young
age at diagnosis for AAs and low income for European Americans (EAs) were predictors for attrition due to lost to
follow-up. High cancer aggressiveness for AAs, low income for EAs, and lower patient provider communication
scores for EAs were predictors for attrition due to refusal. These predictors of nonparticipation were not the same
as those in wave 1. For short follow-up time, the participation probability of EAs was higher than that of AAs.
Conclusions: Predictors of attrition can vary depending on the attrition source. Examining overall attrition
(combining all sources of attrition under one category) instead of distinguishing among its different sources should
be avoided. The factors affecting attrition in one wave can be different in a later wave and should be studied
separately.
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Background
Nonresponse occurs when a sampled subject fails to re-
spond to a survey either partially (item nonresponse) or
entirely (unit nonresponse). Unit nonresponse reduces
sample size and study power. Significant differences be-
tween respondents and non-respondents can cause non-
response bias, which is a type of selection bias [1].
Attrition occurs in a longitudinal study when a partici-
pant fails to respond to one or more study follow-up
waves. A participant may skip one wave but subsequently
respond to a later wave (intermittent) or may quit the
study completely (drop-out). Since the accumulation of
drop-outs over several waves can reduce the representa-
tiveness of the target population, nonresponse is even
more of a concern in longitudinal studies. Problems from
attrition in longitudinal studies are similar to those from
nonresponse in cross-sectional surveys; they reduce study
power and cause bias in estimates if certain subpopula-
tions are over- or under-represented in the sample. Attri-
tion can accumulate with each study wave, creating a final
sample that could differ in characteristics from the ori-
ginal sample. Attrition due to death and decline in the
health of study participants might cause particular
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problems in health-related studies of older people, because
those who continue to participate would be healthier [2].
Nonresponse rates to epidemiologic studies have been
observed to increase in recent years regardless of the
disease studied, geographical region or age of the study
population [3–10]. Morton et al. [11] abstracted infor-
mation from 355 research articles and found that the de-
clines in participation rates were particularly sharp in
population-based case control studies, with an average
decrease of 1.18% for cases and 1.49% for controls per
year from 1970 to 2003. Such increases in nonresponse
are paralleled in other disciplines. Curtin et al. [12] stud-
ied response to a telephone-based survey of consumer
attitudes from 1979 through 2003 and observed a de-
crease in total response rate (from 72 to 48%) and an in-
crease in refusal rate (from 19 to 27%) over time, with
accelerating rates of decline in response for the period
1996–2003. In two longitudinal studies of recovery from
coronary events, the drop-out rates ranged from 15 to
40%, causing a participant loss as high as 70% [13]. A
longitudinal study of drug and alcohol use in adolescents
lost almost 25% of the original cohort at 1 year
follow-up [14].
Several theories exist for the increase in nonre-
sponse. A decrease in social responsibility and an in-
crease in privacy concerns have led individuals to be
more reluctant to participate in surveys [15]. A rise
in surveys has created research fatigue [8, 15]. Dis-
trust of science and researchers, especially in
non-European American (EA) communities, has hin-
dered study recruitment efforts [16, 17]. Additional
theories exist for increased attrition, such as loss of
interest, moving and life changes [13]. Study fatigue
also affects attrition, especially in older populations
due to increased cognitive impairment and morbidity
[13, 18]. Consequently, numerous studies have been
conducted to determine which persons are more
likely to be non-respondents or drop-outs. Males,
people who are less educated, unemployed,
not-married or of lower economic status are less
likely to participate in cross-sectional studies. Results
regarding age are less consistent, with some studies
showing those who are younger having lower partici-
pation propensity than those who are older and other
studies showing the opposite [8]. Generally, those
who are more disadvantaged and in poorer health
tend to be non-respondents [19]. Characteristics of
drop-outs are similar. Males, people with less educa-
tion, not-married, of lower economic status, of small
household size, of poor health status, ethnic minority,
or living in urban areas are at greater risk of attrition
[13, 20, 21]. The effect of age on attrition is unclear,
with some studies reporting increased attrition with
old age and others reporting the opposite [22].
Longitudinal studies that focused on older cohorts
generally reported a negative effect of old age on at-
trition. Older age, low education, and longer distance
between the study center and the participant’s resi-
dence affected attrition in the Baltimore Longitudinal
Study of Aging [23]. Increasing age and cognitive im-
pairment were consistently related to increased attri-
tion in a systematic review of 12 longitudinal studies
in elderly populations [24].
Many strategies have been proposed to minimize non-
response. Monetary incentives and advance letters have
been shown to increase participation [15, 25]. Increasing
interview attempts during evening hours might help to
establish contact [1, 15]. Reminder letters can be sent to
notify participants about when they will be contacted for
the study. Interviewers’ interaction with potential partic-
ipants might impact refusals; thus training interviewers
regarding how to tailor their behavior while recruiting
might help minimize refusals [1]. More experienced,
extroverted and conscientious interviewers can increase
participation [26]. Recruiting minority populations might
require additional strategies. Organizing community out-
reach events, using racially diverse interviewers, and
providing a toll free number might be beneficial in
recruiting non-EA participants and for creating and
maintaining trust [16, 27]. Note that an approach with a
specific subgroup in a specific study may not work with
a similar group under different circumstances. A com-
bination of strategies should be used while monitoring
the survey process in real time and modifying them as
needed to decrease nonresponse and minimize racial/
ethnic differences between respondents and
non-respondents [28].
Attrition also can be minimized by offering incentives,
sending postcards and scheduling telephone reminders.
Collecting detailed contact information from partici-
pants at each wave could especially be useful in longitu-
dinal studies with long follow-up times. A longitudinal
study on adolescent drinking that maintained contact
with 97% of its sample after 18 months initially asked
participants not only for their personal contact informa-
tion, but also for the contact information of adults and
friends who could locate them if future contact was lost
[29]. Re-contacting and re-interviewing participants who
miss a study wave and bringing them back at later waves
can help reduce overall attrition [30]. Newsletters may
be used to update study participants on study progress
in between waves to prevent attrition in longitudinal
studies with long follow-up times. Community engage-
ment, tracing noncontacts, utilizing mixed survey modes
and providing incentives also have been shown to reduce
attrition [21].
Statistical techniques can be used to adjust for nonre-
sponse and attrition after collecting the data, but these
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procedures are not absolute. When auxiliary data exist,
weighting procedures can reduce nonresponse bias, but
they may bias estimates of standard errors. Small or
large weights might create instabilities in estimates. Mul-
tiple imputation techniques can be used to replace miss-
ing data due to attrition by modeling the missingness;
however, specifying the correct model from available
data is difficult [31]. Optimal recruitment strategies
should be implemented before and during data collec-
tion because post-survey adjustments are merely esti-
mated remedies to the problems caused by nonresponse
and attrition [28].
Current research on attrition usually does not differen-
tiate between attrition through refusals and attrition
through other reasons, such as death or lost to
follow-up; however different sources of attrition have
been shown to have different determinants [32]. In this
study, we distinguished between different sources of at-
trition. We evaluated the potential predictors of attrition
in the second wave of a study of prostate cancer (PCa).
Research on attrition is commonly based on the charac-
teristics of non-respondents at wave 1 to explain attri-
tion in later waves, which ignores the role of events after
wave 1. However, attrition models fit to early waves may
become less predictive of attrition in future waves [32].
In order to compare the differences between the two
waves of the same study group, we defined “nonpartici-
pation” as “attrition through refusals”. We compared
these findings with our previous nonparticipation ana-
lyses of the same Louisiana (LA) cohort [28] and evalu-
ated if the factors affecting refusals were the same in
each wave. Specifically, we assessed if racial differences
regarding refusals were consistent over time.
Methods
The North Carolina-Louisiana prostate cancer project
(Wave 1)
The North Carolina-Louisiana Prostate Cancer Project
(PCaP) is a multidisciplinary population-based case-only
study designed to identify racial and geographic influ-
ences on PCa aggressiveness. The study collected infor-
mation on social, individual, and tumor level factors.
Eligibility criteria included living in the North Carolina
(NC) or LA study areas, having first diagnosis of histo-
logically confirmed adenocarcinoma of the prostate, be-
ing 40–79 years old at PCa diagnosis, being able to
complete the interview in English, living outside an insti-
tution, not being cognitively impaired or physically se-
verely debilitated, and not being under the influence of
severe medication or alcohol, or apparently psychotic at
the time of the interview [33]. Demographic and socio-
economic characteristics of LA participants in PCaP
(PCaP-LA) were described in Brennan et al. [34]. The
PCaP-LA cohort started enrollment in September 2004
but suspended accrual in August 2005 due to Hurricane
Katrina. This study phase is referred to as the
pre-Katrina (Pre-K) sample, which enrolled 119
African-Americans (AAs) and 94 EAs. The post-Katrina
(Post-K) enrollment resumed in September 2006 and
completed in August 2009 with 506 AA and 508 EA par-
ticipants [28, 34].
The quality of life in prostate cancer project (Wave 2)
The Quality of Life in Prostate Cancer Project (Q-PCaP)
is a follow-up study of the LA PCaP participants who
were re-contacted 3–6 years after their initial interview.
The follow-up study sought to investigate racial dispar-
ities in quality of life in men with PCa. All study partici-
pants enrolled in PCaP who completed the baseline
interview and consented for future contact were eligible
for Q-PCaP [34].
Unit nonresponse in the PCaP-LA cohort
Our group previously collected auxiliary information on
refusals of the PCaP-LA cohort by combining data from
LA Tumor Registry (LTR), U.S. census tract and PCaP
eligibility forms, and evaluated factors affecting nonpar-
ticipation in PCaP with a specific focus on race, PCa
diagnosis age, and study phase (Pre-K vs Post-K) [28].
Results showed that older age for AAs (≥70 years), high
neighborhood poverty for EAs, and study phase for both
races were significant predictors of nonparticipation
among eligible PCaP-LA research subjects [28]. In this
study, we compared previous findings from wave 1 [28]
with the current analyses from wave 2 to evaluate
whether the factors affecting nonparticipation had chan-
ged with respect to the waves.
Measures
Same or equivalent characteristics to those modeled pre-
viously [28] were included in our analyses to allow for
comparisons; however in the current analyses, the aggre-
gate and LTR based data used previously were replaced
by individual-level data collected at wave 1. Age at diag-
nosis, race, and study phase were categorized as before
[28]. We replaced the Gleason score and tumor stage
used previously [28] by cancer aggressiveness, which is a
composite score of Gleason score, tumor stage, and PSA
at PCa diagnosis [35]. Census tract poverty was replaced
with income and categorized as in Song et al. [35]. Rural
density and parish were excluded in the current analyses
since these factors pertained to Hurricane Katrina and
thus to wave 1. We included additional factors in our
models. Education was dichotomized as ≤high school
and > high school as in Song et al. [35]. The Rapid Esti-
mate of Adult Literacy in Medicine (REALM) short form
[36], which measures health literacy, was categorized as
≤sixth grade (scores 0 to 44), seventh to eighth grade
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(scores 45 to 60), or high school (scores 61 to 66). Pa-
tient provider communication (PPC) score was mea-
sured using a 5-items indicator and adapted subscales
from the Primary Care Assessment Survey 1995 Safran/
The Health Institute [37], where higher scores indicate
more positive communication between the patient and
provider during PCa treatment. The Charlson Comor-
bidity Index (CCI) [38] was constructed from a comor-
bidity questionnaire where higher scores indicate more
comorbidities.
Statistical analyses
Binomial exact tests were used to compare sources of at-
trition in wave 2 with respect to race. Pearson
chi-square tests and two-sample t-tests were used to as-
sess associations between characteristics of wave 1 re-
spondents and participation status in wave 2. Attrition
was modeled using multinomial logistic regression. Ra-
cial differences in the attrition sources were assessed
using race-stratified logistic regression and Firth’s penal-
ized likelihood models; Firth’s logistic regression models
were used to solve the problem of separation and reduce
the bias of the maximum likelihood estimates due to low
event rates after stratification. Survival analyses were
performed to assess the impact of the follow-up time
(time between the two waves) on participation.
Kaplan-Meier estimates were calculated assuming that
the event of interest is participation in wave 2. Time to
event was considered to be the time since wave 1 (in
years) and calculated as follows: For respondents of wave
2, the time difference between wave 1 and wave 2 inter-
views was calculated. Time to event was assigned a zero
for the 46 participants who refused further contact at
wave 1 interview. All drop-outs were considered to be
censored observations, and the time to event was calcu-
lated as the time difference between wave 1 interview
date and February 28, 2013, which was the last day of
wave 2 data collection. To use the Kaplan Meier estima-
tion technique, we assumed that the non-informative
censoring assumption was satisfied by assuming time to
participate in wave 2 (survival time) is independent of
time to drop-out after wave 1 (censoring time). Add-
itionally, we assumed that the participation probabilities
were the same for research subjects recruited early and
recruited late in PCaP. The Wilcoxon test was used to
assess differences in participation probabilities between
races. All statistical analyses were performed using SAS
9.4 (SAS Institute, Inc., Cary, North Carolina).
Results
Of 1227 PCaP LA participants, 46 refused further con-
tact at the time of wave 1. Contact was attempted for
the remaining 1181 participants of whom 118 were de-
ceased, 23 were too frail at the time of wave 2, 87 were
lost to follow-up, and 189 refused to participate. The
reasons for attrition stratified by race are shown in
Table 1. The most common reason for attrition among
AAs was active refusal, followed by lost to follow-up. In
EAs, the most common reason for attrition also was ac-
tive refusal, but followed by being deceased. More AAs
than EAs dropped out overall (p = 0.001), were lost to
follow-up (p < 0.001) and passively refused (interview
was scheduled but never completed) to participate in
wave 2 (p = 0.005).
All baseline characteristics were significantly associ-
ated with attrition in wave 2 (Table 2). A larger percent-
age of wave 2 drop-outs were diagnosed between 60 and
69 years old, AA, had an income of $30,000 or less, had
an education of high school or less, had a REALM score
of high school, and had low cancer aggressiveness. While
the average PPC score was lower among drop-outs than
respondents (p = 0.011), the average CCI was higher (p
= 0.030). Attrition rates also were calculated for each
characteristic from the formulas given in the American
Association of Public Opinion Research (AAPOR) [39]
and provided in Table 2. For example, the attrition rate
of men diagnosed between 40 and 59 years old was the
number of drop-outs for that category, 142, divided by
the total number of men for that category, 395, or 36%.
The overall attrition rate was 38%; the greatest attrition
rate occurred for wave 1 participants with high cancer
aggressiveness (55%).
Results of the multinomial logistic regression are
shown in Table 3. Attrition because of death was less
likely to occur among men who enrolled in wave 1 after
Katrina than those who enrolled before it (OR = 0.6, 95%
CI: 0.32–0.95). Men with high cancer aggressiveness at
wave 1 were 4.5 times more likely to be deceased in
wave 2 than those with low aggressiveness (95% CI:
2.54–7.86). The odds of attrition from death increased
1.3 times for every unit increase in CCI (95% CI: 1.12–
1.46). Men who enrolled in wave 1 after Katrina were
Table 1 Sources of attrition in wave 2 overall and stratified by
raceb
Sources of Attrition N (%) AAa (%) EAa (%) p-valuec,d
Deceased 118 (26) 59 (50) 59 (50) 1.000
Frail 23 (5) 13 (57) 10 (44) 0.532
Lost to Follow-Up 87 (19) 69 (79) 18 (21) < 0.001
Passive Refusal 29 (6) 22 (76) 7 (24) 0.005
Active Refusale 206 (45) 103 (50) 103 (50) 1.000
Total 463 (100) 266 (58) 197 (43) 0.001
aAA african american, EA european american
bTotal participants of wave 2 = 764 men (62%)
cp-values were obtained from binomial exact tests separately for each reason
to assess racial differences
dSignificant p-values at Type I error 0.05 are bolded
eIncludes 46 men who refused further contact at the time of wave 1
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less likely to be drop-outs due to frailty (OR = 0.2, 95%
CI: 0.08–0.67). Attrition due to lost to follow-up was less
likely among men 60 and older at diagnosis than those
younger than 60 (OR = 0.4, 95% CI: 0.22–0.74). AAs
were 2.8 times more likely to be lost to follow-up than
EAs (95% CI: 1.38–5.62). Men with an income $30,000
or less at wave 1 were 4 times more likely to drop out at
wave 2 due to lost to follow-up than those with income
more than $70,000 (95% CI: 1.59–10.41). Having an edu-
cation of high school or less significantly increased the
odds of being lost to follow-up compared to having a
higher education (OR = 2.2, 95% CI: 1.10–4.23). Men
with an income less than $70,000 were more likely to re-
fuse to participate in wave 2 than those with higher in-
come (OR = 1.8, 95% CI: 1.09–2.81). Men with a
REALM score seventh to eighth grade at wave 1 were
less likely to refuse to participate in wave 2 compared to
those with a high school REALM score (OR = 0.6, 95%
CI: 0.37–0.99). While high cancer aggressiveness at wave
1 increased the odds of refusal in wave 2 (OR = 1.6, 95%
CI: 1.06–2.55), every one unit increase in PPC score de-
creased it 0.8 times (95% CI: 0.62–0.93).
The results from race-stratified logistic regression and
Firth’s penalized likelihood models are presented in
Table 2 Comparison of respondents and drop-outs in wave 2 by their characteristicsb
Characteristic Respondents (%) Drop-Outs (%) p-valued, c Attrition Rate (%)
Age at Diagnosis 0.009
40–59 33 31 36
60–69 45 40 35
70–79 22 29 45
Race < 0.001
AAa 47 58 43
EAa 53 43 33
Study Phase 0.010
Post-Ka 85 79 36
Pre-Ka 15 21 46
Income < 0.001
$0–30,000 35 53 47
$30,001–70,000 34 32 36
≥ $70,001 32 16 23
Education < 0.001
≤ High School 42 61 47
> High School 58 39 29
REALMa Score < 0.001
≤ 6th Grade 19 34 52
7th or 8th Grade 21 20 37
High School 60 46 32
Cancer Aggressiveness < 0.001
Low 54 44 33
Intermediate 32 28 34
High 14 28 55
PPCa Score 0.011
Mean (SD) 3.88 (0.79) 3.75 (0.89) 38
CCIa 0.030
Mean (SD) 0.97 (1.41) 1.15 (1.47) 38
aAA african american, EA european american, Post-K post-katrina, Pre-K pre-katrina, REALM rapid estimate of adult literacy in medicine, PPC patient provider
communication, CCI charlson comorbidity index
bMissing data: Income (n = 155), Education (n = 2), REALM score (n = 2), Tumor aggressiveness (n = 83), PPC score (n = 16), CCI (n = 4)
cPearson chi-square tests for categorical variables and two-sample t-tests for continuous variables were used to assess associations between characteristics and
participation status. Note that for the PPC score, the p-value for equality of variances was 0.004, thus Satterhwaite’s approximation was used; for the CCI the p-
value for equality of variances was 0.2878
dSignificant p-values at Type I error 0.05 are bolded
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Table 3 Estimated adjusted odds ratios for attrition with 95% Confidence Intervalsc, b
Attrition
Deceased Frail Lost to Follow-Up Refusal
Age at Diagnosis 70–79 1.87 (0.99–3.51) 3.32 (0.94–11.73) 0.37 (0.16–0.83) 1.28 (0.81–2.03)
60–69 1.00 (0.55–1.84) 0.62 (0.15–2.58) 0.41 (0.22–0.74) 0.93 (0.62–1.39)
Race AAa 0.78 (0.46–1.34) 1.34 (0.42–4.26) 2.79 (1.38–5.62) 1.03 (0.71–1.51)
Study Phase Post-Ka 0.55 (0.32–0.95) 0.24 (0.08–0.67) 1.21 (0.58–2.52) 0.74 (0.48–1.16)
Income $0–30,000 1.99 (0.91–4.35) 2.31 (0.38–13.94) 4.07 (1.59–10.41) 1.78 (1.05–3.02)
$30,001–70,000 1.79 (0.85–3.74) 2.33 (0.43–12.67) 1.83 (0.70–4.79) 1.75 (1.09–2.81)
Education ≤ High School 1.30 (0.74–2.29) 0.76 (0.22–2.57) 2.15 (1.10–4.23) 1.35 (0.91–2.02)
REALMa Score ≤ 6th 1.71 (0.85–3.44) 2.38 (0.52–10.84) 1.01 (0.48–2.15) 0.93 (0.56–1.56)
7th - 8th 0.96 (0.50–1.86) 1.01 (0.24–4.31) 0.72 (0.33–1.55) 0.61 (0.37–0.99)
Cancer Aggressiveness Intermediate 1.38 (0.78–2.44) 0.84 (0.29–2.41) 0.89 (0.47–1.68) 0.78 (0.52–1.15)
High 4.47 (2.54–7.86) 0.28 (0.03–2.29) 1.77 (0.90–3.46) 1.64 (1.06–2.55)
PPCa Score 0.80 (0.61–1.05) 0.79 (0.43–1.44) 1.10 (0.79–1.54) 0.76 (0.62–0.93)
CCIa 1.28 (1.12–1.46) 0.82 (0.53–1.26) 0.78 (0.61–1.01) 0.99 (0.88–1.12)
aAA african american, Post-K post-katrina, REALM rapid estimate of adult literacy in medicine, PPC patient provider communication, CCI charlson comorbidity index
bReferent categories: Age: 40–59 age group, Race: EA, Study phase: Pre-K, Income: ≥$70,001, Education: high school, REALM score: high school, and Cancer
aggressiveness: low
cSignificant p-values at Type I error 0.05 are bolded
Table 4 Estimated adjusted odds ratios for attrition in wave 2, stratified by racef, g
Deceased or Frailb, c Lost to Follow-Upb, d Refusale
AAa EAa AA EA AA EA
Age at Diagnosis 70–79 2.03 (0.89–4.61) 2.30 (0.98–5.44) 0.36 (0.14–
0.93)
0.27 (0.06–1.23) 1.03 (0.5–2.11) 1.38 (0.73–2.60)
60–69 0.81 (0.37–1.73) 1.06 (0.45–2.48) 0.37 (0.18–
0.73)
0.47 (0.15–1.53) 0.99 (0.57–1.73) 0.84 (0.46–1.53)
Study Phase Post-Ka 0.41 (0.20–0.88) 0.46 (0.22–
0.94)
1.12 (0.48–2.62) 0.96 (0.25–3.72) 0.76 (0.40–1.45) 0.73 (0.38–1.40)
Income $0–30,000 13.42 (0.84–
214.98)
1.49 (0.58–3.78) 2.48 (0.86–7.13) 8.65 (1.88–
39.77)
1.01 (0.44–2.30) 2.79 (1.34–
5.81)
$30,001–
70,000
14.13 (0.88–
225.87)
1.21 (0.56–2.63) 1.48 (0.49–4.45) 1.99 (0.44–9.05) 1.34 (0.61–2.95) 1.96 (1.07–
3.58)
Education ≤ High
School
1.37 (0.63–2.99) 1.15 (0.55–2.42) 1.92 (0.90–4.09) 2.18 (0.68–7.05) 1.34 (0.75–2.41) 1.29 (0.73–2.30)
REALMa Score ≤ 6th 1.36 (0.58–3.21) 0.95 (0.26–3.44) 1.18 (0.51–2.74) 0.46 (0.07–2.91) 0.94 (0.47–1.86) 0.81 (0.33–2.00)
7th - 8th 0.47 (0.18–1.20) 2.20 (0.98–4.92) 0.74 (0.30–1.80) 1.25 (0.35–4.52) 0.62 (0.31–1.21) 0.64 (0.30–1.39)
Cancer
Aggressiveness
Intermediate 1.12 (0.55–2.30) 1.16 (0.55–2.45) 1.01 (0.49–2.06) 0.66 (0.20–2.23) 1.03 (0.59–1.80) 0.57 (0.32–1.01)
High 2.98 (1.34–6.62) 4.09 (1.94–
8.63)
2.17 (0.99–4.76) 1.17 (0.28–4.90) 2.51 (1.34–
4.72)
1.07 (0.54–2.10)
PPCa Score 0.77 (0.54–1.09) 0.91 (0.60–1.38) 1.23 (0.83–1.81) 1.05 (0.53–2.10) 0.76 (0.58–1.01) 0.70 (0.51–
0.96)
CCIa 1.26 (1.03–1.54) 1.17 (0.98–1.39) 0.86 (0.65–1.12) 0.91 (0.61–1.37) 1.00 (0.83–1.21) 0.96 (0.80–1.15)
aAA african american, EA european american, Post-K post-katrina, REALM rapid estimate of adult literacy in medicine, PPC patient provider communication, CCI
charlson comorbidity index
bFirth’s logistic regression models were used to reduce potential effects of low event rates
cThe outcome variable was dichotomized as deceased or frail vs participant
dThe outcome variable was dichotomized as lost to follow-up vs participant
eThe outcome variable was dichotomized as refusal vs participant
fSignificant p-values at Type I error 0.05 are bolded
gReferent categories: Age: 40–59 age group, Race: EA, Study phase: Pre-K, Income: ≥$70,001, Education: high school, REALM score: high school, and Cancer
aggressiveness: low
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Table 4. The deceased and frail categories were com-
bined due to the small numbers in the frail category.
Both AAs and EAs who enrolled in wave 1 after Katrina
were less likely to be deceased or frail than those who
enrolled before Katrina (OR = 0.4, 95% CI: 0.20–0.88 and
OR = 0.5, 95% CI: 0.22–0.94, respectively). Both AAs and
EAs with high cancer aggressiveness were more likely to
drop out because of death or frailty than those with low
cancer aggressiveness (OR = 3.0, 95% CI: 1.34–6.62 and
OR = 4.1, 95% CI: 1.94–8.63, respectively). Every one
unit increase in CCI increased the odds of AAs being
deceased or frail at wave 2 (OR = 1.3, 95% CI: 1.03–
1.54), but the corresponding odds among EAs were not
significant. AAs 60 and older at diagnosis were less likely
to be lost to follow-up than AAs with younger age (OR
= 0.4, 95% CI: 0.18–0.73). Although older age for EAs
had similar associations with being lost to follow-up,
these associations did not reach statistical significance.
EAs with an income $30,000 or less were 8.7 times more
likely to be lost to follow-up than those with an income
more than $70,000 (95% CI: 1.88–39.77). Income was
not a significant predictor of being lost to follow-up in
AAs. Education was no longer a significant predictor for
lost to follow-up for either AAs or EAs. AAs with high
cancer aggressiveness were 2.5 times more likely to re-
fuse to participate in wave 2 than those with low cancer
aggressiveness (95% CI: 1.34–4.72). EAs with income
$30,000 or less (OR = 2.8, 95% CI: 1.34–5.81) or with in-
come between $30,001 and 70,000 (OR = 2.0, 95% CI:
1.07–3.58) were more likely to be refusals than those
with income more than $70,000. Income was not a sig-
nificant predictor of refusal in AAs. The odds of refusal
in EAs decreased 0.7 times for every unit increase in
PPC score (95% CI: 0.51–0.96). REALM score was not a
significant predictor for refusal in either race.
The overall and race-stratified product-limit estimates
and 95% CIs, and their accompanying Kaplan-Meier
survival curves are provided in Table 5 and Fig. 1, re-
spectively. In the overall cohort, the probability of par-
ticipating in wave 2 decreased to 50% (95% CI: 46.9–
52.8), 4.64 years after the baseline interview. When
stratified by race, the probability of participating in wave
2 decreased to 50% (95% CI: 45.6–54.1), 4.65 years after
the baseline interview for AAs, and it decreased to 50%
(95% CI: 45.7–53.8), 4.66 years after the baseline inter-
view for EAs. The estimated curve for EAs was above
the one for AAs until the curves crossed at 4.66 years
after wave 1 (Fig. 1b). Although the probability of par-
ticipating at wave 2 was higher for EAs initially, the
probability of participating in wave 2 became slightly
higher for AAs after 4.66 years. The probability of par-
ticipating in wave 2 decreased to 20% both in the overall
sample and in both races 8 years after the baseline inter-
view. The Wilcoxon test for equality of participation
probabilities was significant (p < 0.0001), which indicated
a short-term difference in participation probabilities be-
tween races with respect to follow-up times.
Discussion
The results showed that enrollment in wave 1 before
Katrina was a significant predictor of attrition due to
death or frailty, both for the overall sample and for both
races. High cancer aggressiveness significantly increased
the odds of attrition due to death or frailty for both
races, yet higher CCI increased the odds of attrition due
to death or frailty only in AAs. The results for attrition
due to lost to follow-up in the overall model were con-
sistent with literature that has found minorities and
those with lower education are more likely to be lost to
follow-up [40]. Although lower education was signifi-
cantly associated with being lost to follow-up in the
overall model, the association did not reach significance
when the model was stratified by race. For AAs, being
younger than 60 at diagnosis was the only significant
Table 5 Kaplan-Meier survival curve estimates and 95% CIs at different time points, overall and stratified by race
Product-Limit Estimates of Participation in Wave 2
Time Since Wave 1 (Years) Overall AAa EAa
3.00 1.0 1.0 1.0
4.00 0.766 (0.740–0.789) 0.682 (0.642–0.718) 0.851 (0.819–0.877)
4.64 0.500 (0.469–0.528) 0.502 (0.458–0.544) 0.507 (0.466–0.547)
4.65 0.497 (0.467–0.526) 0.500 (0.456–0.541) 0.506 (0.464–0.545)
4.66 0.493 (0.463–0.522) 0.500 (0.456–0.541) 0.500 (0.457–0.538)
4.70 0.489 (0.459–0.519) 0.499 (0.453–0.539) 0.491 (0.450–0.531)
5.00 0.441 (0.411–0.470) 0.461 (0.417–0.504) 0.434 (0.393–0.474)
6.00 0.325 (0.294–0.356) 0.363 (0.316–0.409) 0.301 (0.261–0.343)
7.00 0.203 (0.173–0.236) 0.214 (0.169–0.262) 0.203 (0.162–0.248)
8.00 0.198 (0.167–0.230) 0.204 (0.160–0.252) 0.203 (0.162–0.248)
aAA african american, EA european american
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predictor for attrition due to lost to follow-up. After
hurricane Katrina, the loss of rental housing inflated
rental housing costs in the New Orleans area [41].
Younger AAs may have relocated to more affordable
housing. For EAs, the only significant predictor for attri-
tion due to lost to follow-up was low income (≤$30,000).
EAs with low income may have been residing in rentals
and had to relocate to more affordable rental units after
Katrina. Also, homeowners relying on federal disaster as-
sistance received payments several years after Katrina
that often were not enough to rebuild their homes [41];
EAs of low income may have had a temporary residence
during wave 1 and became lost to follow-up once they
were able to rebuild or relocate.
For the same cohort, our group previously showed
that older diagnosis age for AAs (≥70 years), low neigh-
borhood poverty for EAs (< 20% of the households
within the tract living in poverty), and study phase with
respect to Katrina for both races were significant predic-
tors of nonparticipation (refusal) in wave 1 [28]. Age and
study phase were no longer significant predictors of
nonparticipation in wave 2 for either race. Instead, high
cancer aggressiveness for AAs, low income for EAs (≤
$70,000), and lower PPC scores for EAs were the signifi-
cant predictors of nonparticipation in wave 2. One pos-
sible explanation for the opposite effect of income in EA
nonparticipation might be that the compensation for
participation in wave 1 was a maximum of $75, while it
Fig. 1 a Kaplan-Meier Survival Curves for wave 2 (overall).b Kaplan-Meier Survival Curves for wave 2 (stratified by race)
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was only $25 in wave 2. This incentive decrease might
have caused EAs with low income to be less interested
in participating in wave 2. Another explanation can be
provided based on the leverage-salience theory [42]: the
salience and/or leverage of the survey features, such as
busyness, monetary incentive amount, or willingness to
contribute to PCa research, might have changed for EAs
after wave 1. There may have been an additional survey
feature that was not present at wave 1, such as experi-
ence with the interviewer in the first wave, which added
to their leverage and changed their participation. Income
did not alter AAs’ participation in either wave, which
highlights the need for using different approaches to
boost participation of AAs in PCa studies in addition to
providing monetary incentives (see [28]). PPC score,
which is associated with higher patient satisfaction [43,
44], has not been studied to our knowledge in nonre-
sponse/attrition research. These results indicated that a
more positive perception of PPC significantly decreased
the odds of refusals, both in the overall sample and in
EAs. PCa researchers should encourage providers to
promote their patients’ ongoing study involvement
throughout longitudinal data collection.
In longitudinal studies, longer follow-up periods are
well known to be associated with higher attrition, but
the degree of this association has not been studied well
[45, 46]. The results from survival analyses showed that
the participation probability of EAs was higher than the
participation probability of AAs when the length of
follow-up was shorter than 4.66 years. However, these
probabilities were reversed when the follow-up time in-
creased. Thus, racial differences may need to be consid-
ered when planning follow-up times. PCa researchers
should keep the times between waves short when con-
ducting longitudinal studies. However, the survival ana-
lyses were limited by lack of information on exact time
of attrition. Further research needs to be done on the ef-
fect of exact time between waves on attrition to confirm
these findings.
Conclusions
We assessed factors affecting attrition in the second wave
of a population-based study of PCa. Studies have been
conducted in various populations, including elderly, to de-
termine the effects of health on nonresponse and attrition
[2, 13, 30]. But, to our knowledge, no such study exists
specifically for PCa populations, which are prone to both
aging and frailty. The large and approximately equal sam-
ple sizes of AAs and EAs enabled us to assess the racial
differences in attrition. Our results verified the need for
studying sources of attrition separately when possible;
examining attrition without distinguishing between its dif-
ferent sources can cause separate factors to be missed.
Our results also demonstrated the danger of using one
wave of a longitudinal study to evaluate nonresponse in
later waves. Unless the interval between waves is very
short, strategies used to decrease attrition at an earlier
wave may not be useful at the time of a subsequent wave
because the salience and/or leverage of the study features
might change for participants over time. The factors af-
fecting attrition and nonparticipation should be studied
constantly at each wave to tailor ongoing retention efforts
in longitudinal studies.
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